[go: up one dir, main page]

AU1081401A - Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene - Google Patents

Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene

Info

Publication number
AU1081401A
AU1081401A AU10814/01A AU1081401A AU1081401A AU 1081401 A AU1081401 A AU 1081401A AU 10814/01 A AU10814/01 A AU 10814/01A AU 1081401 A AU1081401 A AU 1081401A AU 1081401 A AU1081401 A AU 1081401A
Authority
AU
Australia
Prior art keywords
polymorphisms
acetylcholine receptor
receptor gene
drug target
muscarinic acetylcholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU10814/01A
Other languages
English (en)
Inventor
Julie Y. Choi
R. Rex Denton
Krishnan Nandabalan
J. Claiborne Stephens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cogenics Inc
Original Assignee
Genaissance Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genaissance Pharmaceuticals Inc filed Critical Genaissance Pharmaceuticals Inc
Publication of AU1081401A publication Critical patent/AU1081401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/125—Allele specific primer extension
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU10814/01A 1999-10-13 2000-10-12 Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene Abandoned AU1081401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15926999P 1999-10-13 1999-10-13
US60/159269 1999-10-13
PCT/US2000/028211 WO2001027312A2 (fr) 1999-10-13 2000-10-12 Isogenes cibles pour medicaments: polymorphismes dans le gene recepteur de l'acetylcholine muscarinique m1

Publications (1)

Publication Number Publication Date
AU1081401A true AU1081401A (en) 2001-04-23

Family

ID=22571819

Family Applications (1)

Application Number Title Priority Date Filing Date
AU10814/01A Abandoned AU1081401A (en) 1999-10-13 2000-10-12 Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene

Country Status (2)

Country Link
AU (1) AU1081401A (fr)
WO (1) WO2001027312A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001280727A1 (en) * 2000-07-21 2002-02-05 Genaissance Pharmaceuticals, Inc. Haplotypes of the adrb3 gene
AU2003288250A1 (en) * 2002-12-23 2004-07-14 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with muscarinic acetylcholine receptor m1 (acm1)
CN100383245C (zh) * 2003-11-07 2008-04-23 首都医科大学附属北京朝阳医院 扩张性心肌病病人m2－乙酰胆碱能受体突变基因及其检测方法
CN101215564B (zh) * 2003-11-07 2011-06-22 首都医科大学附属北京朝阳医院 扩张性心肌病病人m2-乙酰胆碱能受体突变基因

Also Published As

Publication number Publication date
WO2001027312A3 (fr) 2002-01-10
WO2001027312A2 (fr) 2001-04-19

Similar Documents

Publication Publication Date Title
MXPA01010676A (es) Composicion farmaceutica de vitamina d o un analogo de vitamina d y al menos un corticoesteroide.
ZA200000857B (en) Pharmaceutical composition.
AU3178200A (en) Genetic analysis
AU1824201A (en) Polymorphisms in the human HMG-COA reductase gene
AU7119400A (en) Single nucleotide polymorphisms in genes
AU5786300A (en) Muscarinic antagonists
AU1081401A (en) Drug target isogenes: polymorphisms in the m1 muscarinic acetylcholine receptor gene
AU6492400A (en) Drug target isogenes: polymorphisms in the prostaglandin-endoperoxide synthase 2gene
AU1922801A (en) Genomic polymorphism for predicting therapeutic response
AU2000263446A1 (en) Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene
AU6110700A (en) Drug target isogenes: polymorphisms in the dopamine receptor d2 gene
ZA200110454B (en) Pharmaceutical complex.
AU7388700A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine receptor 1a gene
AU2258601A (en) Ibd-related polymorphisms
AU6755300A (en) Drug target isogenes: polymorphisms in the immunoglobulin e receptor i alpha subunit gene
AU1331701A (en) Screening for disease susceptibility by genotyping the ccr5 and ccr2 genes
AU6343400A (en) Drug target isogenes: polymorphisms in the osteoclastogenesis inhibitory factor gene
AU2001213316A8 (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1d gene
AU1338901A (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 5 gene
AU2000280165A1 (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 3 gene
AU2000280150A1 (en) Drug target isogenes: polymorphisms in the cholinergic receptor, muscarinic 2 gene
AU2000236029A1 (en) Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
AU1773501A (en) Human single nucleotide polymorphisms
AU1570701A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1e gene
AU7994500A (en) Drug target isogenes: polymorphisms in the 5-hydroxytryptamine (serotonin) receptor 1b gene

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase